Navigation Links
Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
Date:5/28/2013

pany's product formulation and patient needs and potential funding sources; the Company's staffing needs; and other risk factors set forth discussed under the heading "Risk Factors" contained in Omthera prospectus dated April 11, 2012 filed with the Securities and Exchange Commission pursuant to Rule 424(b) of the Securities Act of 1933, as amended, as well as any updates to these risk factors filed from time to time in the Company's SEC filings made pursuant to the Securities Exchange Act of 1934, as amended. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update the information in this press release to reflect events or circumstances after the date hereof or to reflect the occurrence of anticipated or unanticipated events.

For more information, please visit www.omthera.com

Omthera Contact:
Christian Schade
Executive Vice President & Chief Financial Officer
Omthera Pharmaceuticals
T: 908-741-4399
E: info@Omthera.com

 Omthera Pharmaceuticals, Inc.Condensed Statement of Operations(In thousands, except per share data)(Unaudited)Three months endedMarch 31,20122013Operating expenses:Research and development$8,049$357General and administrative 1,1311,325Total operating expenses9,1801,682Operating loss(9,180)(1,682)Other income (expense):Interest expense, net—(4,574)Other63Net Loss$(9,174)$(6,253)Dividends on Preferred Stock$(909)$(1,094)Net loss attributable to common shareholders$(10,084)$(7,348)Net loss per share – basic and diluted $(6.18)$(3.08)Weighted average number of shares outstanding (post-split)1,631,7272,383,444 Condensed Balance Sheet Information(In thousands)December 31,March 31,20122013(Unaudited)Cash and cash equivalents $2,50
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
2. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
3. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
4. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
5. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
6. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
7. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
8. Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
9. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Worth $825 Million by 2017
10. Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
11. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- San MediTech, the industry leader in ... diabetics, announced its plan to attend the American Diabetes ... on June 5 th to 8 ... System (DGMS). The company plans to show industry experts ... and advancements made by Chinese medical device companies. San ...
(Date:6/2/2015)... today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... LOS ANGELES , June 2, 2015  CytRx ... development company specializing in oncology, today announced that it ... action pending in the Delaware ... of the Company,s current and former directors and officers, ... The lawsuit, captioned In re CytRx Corp. ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4
... MYL ) today commented on its response ... Mylan CEO Heather Bresch said, "We recognize the ... of patients with cancer, particularly the pediatric population, and ... to this important product. While Mylan has not had ...
... IRVINE, Calif., Feb. 14, 2012 Masimo (NASDAQ: ... its mission to "Improve Patient Outcomes and Reduce the Cost ... Applications®," and its confidence that continuous noninvasive hemoglobin monitoring (SpHb®) ... hospital-wide risk-share program for B lood T ransfusion ...
Cached Medicine Technology:Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 2Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 3Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 4Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 5Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 6Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price 7
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low ... (NPE) announcement of three next generation WASP bridge ... WASP-PoE-3. WASP is a standalone ANT (covering ANT, ... that allows data collected from low-power wireless sensors ... , The new generation of WASP ...
(Date:6/2/2015)... CRN International has been named a 2015 ... , a Connecticut state program that takes active steps to ... at appropriate companies. , Platform to Employment is being delivered ... Department of Labor. CRN, a 40-year-old radio marketing company near ... being recognized for its “hard work and dedication.” , CRN ...
(Date:6/2/2015)... Shimadzu Scientific Instruments today announces ... spectrometer. The newest model in the Ultra-Fast Mass ... ultrafast technologies (UF technologies) with new ion guide ... quality and higher throughput for a wide array ... features new technology, including a stronger vacuum system ...
(Date:6/2/2015)... 2015 DuPont Pioneer , one ... new seed warehouse and office facility in Zambia that ... for both local and export markets to Kenya, Tanzania ... emerge as the breadbasket for southern Africa provided an ... and South Central Africa senior business manager of DuPont ...
(Date:6/2/2015)... 2015 PhishLine, LLC today announced ... Swenson Drive, Suite 125 in Waukesha, Wisconsin 53186. ... new base of operations for PhishLine’s current corporate ... growth. , Mark Chapman, Founder and President, commented ... as enterprise customers adopt our market leading service ...
Breaking Medicine News(10 mins):Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Shimadzu’s New LC-MS/MS Provides Superior Speed and Sensitivity for the Utmost in Quantitative Detection and High-Speed Analysis 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2
... 19 California attorneys and a,presiding judge are among ... assemble next month in Los Angeles to discuss emerging ... Robert Berkes of Berkes Crane Robinson ... on asbestos litigation; Steven Kazan of Kazan McClain,Abrams Lyons ...
... (TSX: IM) ("IMRIS" or the "Company") today announced ... development and commercialization of MR-guided radiation therapy and ... (UHN) in Toronto. , The collaboration signals the ... guided radiation therapy, expanding on its existing expertise ...
... Feb. 19 The March of Dimes New York Division announced ... will return for a second year, to lead March for Babies(R) ... CBS 2 News Co-Anchor, Maurice DuBois , WCBS-TV/CBS 2 Sports ... morning program. "I,m very excited to be working with March of ...
... Region that affects addictive behavior is linked to ... (HealthDay News) -- The thrill-seeking behavior that makes ... might be based in an area of the ... , University of Kentucky and Purdue University researchers ...
... not possible, transplanting stem cells from the patient,s own bone marrow ... , The procedure has been tested successfully in ... been shown in 80% of cases, and considerable improvement in quality ... Hospital Clnic has used this therapy in a total of 6 ...
... Awards In January; Additional Cash Prizes Go to Support Best ... WarriorsWHITE PLAINS, N.Y., Feb. 19 Americans, renewed sense of ... the way to online solitaire. Thousands of ... games on behalf of their favorite charity or community organization. ...
Cached Medicine News:Health News:California Attorneys Featured at Major Asbestos Litigation Event 2Health News:IMRIS announces development program for MR guided radiation and interventional applications 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2Health News:Thrill-Seekers' Brains May Be Wired Differently 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 2Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 3
... midi gel dryer can dry 6 pieces of 10 ... area is 21 x 31 cm for laboratories to ... of silicon rubber with mask. Microprocessor controller controls temperature ... and the vacuum removes the moisture from below to ...
... To dry gels rapidly, evenly and safely, ... method. Heat and vacuum are applied beneath the ... Dries acrylamide and agarose gels up to 33 ... minutes., The heavy aluminum platen provides even heat ...
This double-up gel dryer system, 100-120 V, includes 2 Model 583 gel dryers, HydroTech™ vacuum pump, and double-up rack....
... The Model 583 gel dryer is an ... acrylamide and agarose gels and dries these gels ... The dryer incorporates lid-mounted heater elements which heat ... x 45 cm. This 220-240 V unit includes ...
Medicine Products: